O
OrbiMed Portfolio holdings
AUM
$4.89B
1-Year Est. Return
87.75%
This Fund
S&P 500
1 Year Est. Return
+87.75%
AUM
$4.17B
AUM Growth
+$193M
(+4.9%)
Holding
120
Top Buys
| 1 | +$52.4M | |
| 2 | +$48.2M | |
| 3 | +$38.6M | |
| 4 |
Ascendis Pharma
ASND
|
+$29.4M |
| 5 |
Oric Pharmaceuticals
ORIC
|
+$28.9M |
Top Sells
| 1 | +$105M | |
| 2 | +$93.6M | |
| 3 | +$81.8M | |
| 4 |
Boston Scientific
BSX
|
+$39.8M |
| 5 |
Cytokinetics
CYTK
|
+$35.6M |
Sector Composition
| 1 | Healthcare | 99.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
Cytokinetics
CYTK
$7.61B
| – | – |
-1,077,000
|
|
||
102
enGene Holdings
ENGN
$677M
| – | – |
-677,977
|
|
||
103
INmune Bio
INMB
$34.3M
| – | – |
0
|
|
||
|
ITOS
104
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-700,000
|
|
||
105
Pfizer
PFE
$157B
| – | – |
0
|
|
||
106
Scholar Rock
SRRK
$4.52B
| – | – |
0
|
|
||
107
TG Therapeutics
TGTX
$4.78B
| – | – |
0
|
|
||
108
Tenet Healthcare
THC
$20.8B
| – | – |
-465,000
|
|
||
109
Tyra Biosciences
TYRA
$1.78B
| – | – |
-804,603
|
|
||
110
UnitedHealth
UNH
$266B
| – | – |
-336,300
|
|
||
111
Vertex Pharmaceuticals
VRTX
$126B
| – | – |
-210,287
|
|
||
112
Zai Lab
ZLAB
$2.15B
| – | – |
-231,000
|
|
||
|
LSB
113
DELISTED
LakeShore Biopharma
LSB
| – | – |
-54,799
|
|
||
114
Abbott
ABT
$202B
| – | – |
0
|
|
||
115
Agios Pharmaceuticals
AGIO
$1.77B
| – | – |
-557,900
|
|
||
116
AstraZeneca
AZN
$323B
| – | – |
0
|
|
||
|
THRD
117
DELISTED
Third Harmonic Bio
THRD
| – | – |
-5,779,071
|
|
||
|
TSBX
118
DELISTED
Turnstone Biologics
TSBX
| – | – |
-3,099,265
|
|